Cargando…

Identification of an m6A-Related Long Noncoding RNA Risk Model for Predicting Prognosis and Directing Treatments in Patients With Colon Adenocarcinoma

N6-methyladenosine (m6A) and lncRNAs have been implicated in the development of colon cancer, including tumorigenesis, migration, and invasion. However, the specific effect of m6A regulators on lncRNAs is not clear, and m6A-related lncRNAs may be new prognostic biomarkers and may help direct treatme...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liao, Wanying, Long, Junyu, Li, Yiran, Xie, Fucun, Xun, Ziyu, Wang, Yanyu, Yang, Xu, Wang, Yunchao, Zhou, Kang, Sang, Xinting, Zhao, Haitao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cell and Developmental Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9326028/ https://www.ncbi.nlm.nih.gov/pubmed/35912098 http://dx.doi.org/10.3389/fcell.2022.910749

Ejemplares similares

Genome Instability and Long Noncoding RNA Reveal Biomarkers for Immunotherapy and Prognosis and Novel Competing Endogenous RNA Mechanism in Colon Adenocarcinoma
por: Ren, Ziyuan, et al.
Publicado: (2021)

The Efficacy and Safety of Apatinib Plus Camrelizumab in Patients With Previously Treated Advanced Biliary Tract Cancer: A Prospective Clinical Study
por: Wang, Dongxu, et al.
Publicado: (2021)

Development and validation of a selenium metabolism regulators associated prognostic model for hepatocellular carcinoma
por: Sun, Huishan, et al.
Publicado: (2023)

Identification of a glycolysis- and lactate-related gene signature for predicting prognosis, immune microenvironment, and drug candidates in colon adenocarcinoma
por: Liu, Cong, et al.
Publicado: (2022)

Development and validation of a genomic instability-related lncRNA prognostic model for hepatocellular carcinoma
por: Xun, Ziyu, et al.
Publicado: (2023)

Gut microbiome is associated with the clinical response to anti-PD-1 based immunotherapy in hepatobiliary cancers
por: Mao, Jinzhu, et al.
Publicado: (2021)

Efficacy of immune checkpoint inhibitors plus molecular targeted agents after the progression of lenvatinib for advanced hepatocellular carcinoma
por: Xie, Fucun, et al.
Publicado: (2022)

The Pyroptosis-Related Long Noncoding RNA Signature Predicts Prognosis and Indicates Immunotherapeutic Efficiency in Hepatocellular Carcinoma
por: Wang, Tao, et al.
Publicado: (2022)

Integrated Analyses Reveal Potential Functional N6-Methyladenosine-Related Long Noncoding RNAs in Adrenocortical Adenocarcinoma
por: Ding, Yafei, et al.
Publicado: (2022)

N6-Methylandenosine-Related lncRNA Signature Is a Novel Biomarkers of Prognosis and Immune Response in Colon Adenocarcinoma Patients
por: Zhang, Peiling, et al.
Publicado: (2021)

Association of aging-related genes with prognosis and immune infiltration in pancreatic adenocarcinoma
por: Xue, Shengbai, et al.
Publicado: (2022)

Development and Validation of a Novel Hypoxia-Related Long Noncoding RNA Model With Regard to Prognosis and Immune Features in Breast Cancer
por: Gu, Peng, et al.
Publicado: (2021)

Potential diagnostic of lymph node metastasis and prognostic values of TM4SFs in papillary thyroid carcinoma patients
por: Wang, Kun, et al.
Publicado: (2022)

Accurate Prediction of Prognosis by Integrating Clinical and Molecular Characteristics in Colon Cancer
por: Wang, Liru, et al.
Publicado: (2021)

Two Similar Signatures for Predicting the Prognosis and Immunotherapy Efficacy of Stomach Adenocarcinoma Patients
por: Yue, Taohua, et al.
Publicado: (2021)

Machine learning-based identification of a novel prognosis-related long noncoding RNA signature for gastric cancer
por: Zhao, Linli, et al.
Publicado: (2022)

The Construction and Analysis of ceRNA Network and Patterns of Immune Infiltration in Colon Adenocarcinoma Metastasis
por: Chang, Zhengyan, et al.
Publicado: (2020)

An Iron Metabolism-Related Gene Signature for the Prognosis of Colon Cancer
por: Yuan, Jing, et al.
Publicado: (2022)

Association of chronic liver disease with the prognosis of COVID-19 patients
por: Long, Junyu, et al.
Publicado: (2022)

Establishment of a Necroptosis Related Genes Signature to Predict Prognosis and Therapeutic Response in Colon Cancer
por: Wang, Yuan, et al.
Publicado: (2022)

Emerging Roles of Long Noncoding RNAs in Immuno-Oncology
por: Wang, Xin, et al.
Publicado: (2021)

ISYNA1: An Immunomodulatory-Related Prognostic Biomarker in Colon Adenocarcinoma and Pan-Cancer
por: Jia, Zeming, et al.
Publicado: (2022)

CXCL11 Correlates With Antitumor Immunity and an Improved Prognosis in Colon Cancer
por: Cao, Yingying, et al.
Publicado: (2021)

CMTM Family Genes Affect Prognosis and Modulate Immunocytes Infiltration in Grade II/III Glioma Patients by Influencing the Tumor Immune Landscape and Activating Associated Immunosuppressing Pathways
por: Wang, Zeyu, et al.
Publicado: (2022)

CREM Is Correlated With Immune-Suppressive Microenvironment and Predicts Poor Prognosis in Gastric Adenocarcinoma
por: Yu, Kuai, et al.
Publicado: (2021)

Neddylation pattern indicates tumor microenvironment characterization and predicts prognosis in lung adenocarcinoma
por: Cui, Yuan, et al.
Publicado: (2022)

SUMOylation patterns and signature characterize the tumor microenvironment and predict prognosis in lung adenocarcinoma
por: Chen, Zhike, et al.
Publicado: (2023)

The role of long noncoding RNAs in therapeutic resistance in cervical cancer
por: Zhou, Meimei, et al.
Publicado: (2022)

Efficacy, safety, and prognostic factors of PD-1 inhibitors combined with lenvatinib and Gemox chemotherapy as first-line treatment in advanced intrahepatic cholangiocarcinoma: a multicenter real-world study
por: Zhu, Chengpei, et al.
Publicado: (2023)

Identification of lung adenocarcinoma subtypes and predictive signature for prognosis, immune features, and immunotherapy based on immune checkpoint genes
por: Hua, Linbin, et al.
Publicado: (2023)

Identification and verification of a prognostic signature based on a miRNA–mRNA interaction pattern in colon adenocarcinoma
por: Zhao, Qiwu, et al.
Publicado: (2023)

An Immune Panel Signature Predicts Prognosis of Lung Adenocarcinoma Patients and Correlates With Immune Microenvironment
por: Zhou, Yuan, et al.
Publicado: (2021)

Identification of Ferroptosis-Related Genes Signature Predicting the Efficiency of Invasion and Metastasis Ability in Colon Adenocarcinoma
por: Shi, Chunlei, et al.
Publicado: (2022)

Integrative Analysis of 5-Hydroxymethylcytosine and Transcriptional Profiling Identified 5hmC-Modified lncRNA Panel as Non-Invasive Biomarkers for Diagnosis and Prognosis of Pancreatic Cancer
por: Li, Shuangquan, et al.
Publicado: (2022)

A Combined Two-mRNA Signature Associated With PD-L1 and Tumor Mutational Burden for Prognosis of Lung Adenocarcinoma
por: Song, Congkuan, et al.
Publicado: (2021)

Long noncoding RNAs as therapeutic targets to overcome chemoresistance in ovarian cancer
por: Chen, Linjiao, et al.
Publicado: (2022)

High Cancer Susceptibility Candidate 8 Expression Is Associated With Poor Prognosis of Pancreatic Adenocarcinoma: Validated Analysis Based on Four Cancer Databases
por: Wang, Yingyi, et al.
Publicado: (2020)

Noncoding RNAs: an emerging modulator of drug resistance in pancreatic cancer
por: Wei, Ling, et al.
Publicado: (2023)

A Ferroptosis and Pyroptosis Molecular Subtype-Related Signature Applicable for Prognosis and Immune Microenvironment Estimation in Hepatocellular Carcinoma
por: Huo, Junyu, et al.
Publicado: (2021)

Prognosis and Immunotherapy Response With a Novel Golgi Apparatus Signature-Based Formula in Lung Adenocarcinoma
por: Jiang, Yupeng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ar1i0ujm4f3nq2riqnkb52su8b